World's Best Scientists 2026 revealed!
Cancer Science
H-index 48

Cancer Science

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 398 282 465 39

Additional Metrics

Number of Best Scientists*: 752
Documents by Best Scientists*: 895
Top 100 Ranked Scientists*: 27
SCIMAGO H-index: 173
SCIMAGO SJR: 1.661
Impact Factor: 4.3

Overview

Top Research Topics at Cancer Science?

The journal was organized to reinforce research efforts on Cancer research, Cancer, Internal medicine, Pathology and Cancer cell. The research on Cancer research tackled can also make contributions to studies in the areas of Cell culture, Cell growth, Carcinogenesis, Apoptosis and Metastasis. Discussions in the journal are anchored in the subject of Cell culture and the similar topic of Molecular biology.

It holds forums on Cell growth that merges themes from other disciplines such as Downregulation and upregulation and Gene knockdown. While work presented in the journal provided substantial information on Cancer, it also covered topics in Lung cancer and Immunology. Internal medicine research presented in it encompasses a variety of subjects, including Gastroenterology, Endocrinology and Oncology.

The study on Pathology presented is investigated in conjunction with research in Adenocarcinoma. Studies on Cancer cell discussed in Cancer Science link to the field of Cell biology. Signal transduction is part of Cell biology studies tackled in it.

  • Cancer research (47.65%)
  • Cancer (25.72%)
  • Internal medicine (25.19%)

What are the most cited papers published in the journal?

  • Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. (1041 citations)
  • Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression (645 citations)
  • Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1 (586 citations)

Research areas of the most cited articles at Cancer Science:

The journal publications mostly deal with topics like Cancer research, Cancer, Pathology, Internal medicine and Immunology. The Cancer research research presented in the journal articles focuses mostly on Cancer cell and, on occasion, topics in Apoptosis and Cell biology. The journal publications facilitate discussions on Cancer that incorporate concepts from other fields like Lung cancer and microRNA.

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Science (based on the number of publications) are:

  • Yusuke Nakamura (67 papers) published 1 paper at the last edition,
  • Kensei Tobinai (53 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • Hironobu Sasano (41 papers) absent at the last edition,
  • Kazuto Nishio (41 papers) published 4 papers at the last edition,
  • Wataru Yasui (37 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Science (based on the number of publications) are:

  • University of Tokyo (448 papers) published 30 papers at the last edition, 4 more than at the previous edition,
  • Osaka University (262 papers) published 32 papers at the last edition, 6 more than at the previous edition,
  • Nagoya University (255 papers) published 21 papers at the last edition, 4 less than at the previous edition,
  • Tohoku University (235 papers) published 27 papers at the last edition, 12 more than at the previous edition,
  • Kyushu University (223 papers) published 23 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.42% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 35.46% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.75% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.09% of all publications and 35.70% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Pathways in Cancer Research

While diving deep into the knowledge of cancer might seem overwhelming to some, we acknowledge that for others, it sparks a desire to contribute to such crucial research. Hence, for those who want to pursue a career in medical fields like nursing, which often involves dealing with cancer patients, you might be interested in learning more about the entire process. It's important to have an understanding of cancer studies, types of cancer, and their effects, as nurses typically work on the frontline of patient care. This understanding can be a bridge between scientific research and practical application in a medical setting. For those who reside in Washington, if this has piqued your interest, and you're considering the pursuit of a nursing career in relation to cancer studies, you can follow our guide on {anchor}, which provides comprehensive information on how to become a registered nurse in the state. Through this career pathway, you might also find opportunities to contribute to cancer research while making a difference in patients' lives.

Top Publications

  • Tumor microenvironment in gastric cancers.

    Yukiko Oya;Yoku Hayakawa;Kazuhiko Koike

    (2020)
    214 Citations
  • Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma.

    Yoshifumi Baba;Daichi Nomoto;Kazuo Okadome;Takatsugu Ishimoto

    (2020)
    186 Citations
  • Biology and therapeutic potential of mesenchymal stem cell-derived exosomes.

    Zhou Xunian;Raghu Kalluri;Raghu Kalluri;Raghu Kalluri

    (2020)
    175 Citations
  • Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors.

    Chiaki Kurimoto;Hidefumi Inaba;Hiroyuki Ariyasu;Hiroshi Iwakura

    (2020)
    113 Citations
  • Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs

    (2022)
    104 Citations
  • Ferroptosis at the crossroads of infection, aging and cancer

    Shinya Toyokuni;Shinya Toyokuni;Izumi Yanatori;Yingyi Kong;Hao Zheng

    (2020)
    102 Citations
  • Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors.

    Kiwamu Akagi;Eiji Oki;Hiroya Taniguchi;Kaname Nakatani

    (2021)
    95 Citations
  • CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.

    Hiroya Taniguchi;Yoshiaki Nakamura;Daisuke Kotani;Hiroki Yukami

    (2021)
    95 Citations
  • Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells

    Yuki Yokota;Takehiro Noda;Yuichiro Okumura;Shogo Kobayashi

    (2021)
    89 Citations
  • Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.

    Kenji Takahashi;Yu Ota;Takayuki Kogure;Yuko Suzuki

    (2020)
    87 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their career in healthcare beyond traditional medical degrees, there are several online options worth considering. An mba healthcare management online can equip you with the business skills necessary to lead healthcare organizations and improve patient outcomes from an administrative perspective.

Nurses aiming to accelerate their clinical career might explore online accelerated bsn programs for non nurses, designed to fast-track those without a nursing background into the field, enabling a faster transition to bedside care.

For advanced practice nurses, understanding earning potential is essential. The pmhnp salary varies by state but generally reflects the high demand for psychiatric nurse practitioners, showing promising financial prospects.

Lastly, if you're seeking to expedite your journey, fast track nurse practitioner programs offer accelerated pathways to become qualified nurse practitioners in the shortest time possible, balancing quality education with speed.

Best Scientists Contributing to This Journal